Over the last decade rising pressure to reduce costs and time-to-market has lead to a rapid expansion of the global CRO market. Pharmaceutical and biotechnology company spend on CRO service has shown double digit growth in the past years highlighting the importance of this fast growing market. ’The CRO Market Outlook’ assesses the drivers and restraints of the global CRO market, highlighting key trends and identifying offshore outsourcing opportunities in fast-growing emerging markets such as China, India and Latin America. This report also profiles the major international CRO players providing market share data and detailed analysis on current and future R&D spend.
Other selected research from the 'China' category:
China Healthcare Sector Analysis
Chinese healthcare industry is entering into a new phase with the advanced development of infrastructure. The industry enjoys many benefits including, large population, rising aging population, and continuously growing prevalence... Learn More
Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
This report explores the expanding pharma outsourcing market in China to discover how large pharma, small-sized pharma and biotech can most effectively utilize the country’s service offerings and capabilities. Learn More
Other selected research from the 'India' category:
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
Datamonitor’s Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report... Learn More
Booming Pharma Sector in India
This dramatic growth in the Indian pharmaceutical industry can be attributed to several factors such as growing middle class population, rapid urbanization, increase in lifestyle-related diseases and acceptance of health insurance. Learn More
Other selected research from the 'Drug Discovery' category:
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
The last decade has been marked by an unprecedented boom in the number and variety of technologies used to discover and develop new drugs; many of these technologies arose from work surrounding the human genome project. Learn More
The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
G-protein coupled receptors (GPCRs) constitute the largest, most ubiquitous, and most versatile family of membrane receptors. They also constitute the class of targets that has been most effectively exploited... Learn More